financetom
Business
financetom
/
Business
/
Arrow Electronics Q2 Non-GAAP Net Income Falls, Sales Rise; Q3 Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arrow Electronics Q2 Non-GAAP Net Income Falls, Sales Rise; Q3 Outlook Issued
Jul 31, 2025 6:43 AM

09:20 AM EDT, 07/31/2025 (MT Newswires) -- Arrow Electronics ( ARW ) reported Q2 non-GAAP net income Thursday of $2.43 per diluted share, down from $2.78 a year earlier.

Analysts polled by FactSet expected $2.07.

Consolidated sales for the quarter ended June 28 were $7.58 billion, up from $6.89 billion a year earlier.

Analysts surveyed by FactSet expected $7.16 billion.

The company said it expects Q3 non-GAAP net income of $2.16 to $2.36 per diluted share on consolidated sales of $7.3 billion to $7.9 billion. Analysts surveyed by FactSet expect $2.51 and $7.3 billion, respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rivian Automotive Unusual Options Activity
Rivian Automotive Unusual Options Activity
Apr 15, 2024
Whales with a lot of money to spend have taken a noticeably bearish stance on Rivian Automotive ( RIVN ). Looking at options history for Rivian Automotive ( RIVN ) we detected 21 trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 61% with...
Tapestry Secures Approvals in EU, Japan for Planned $8.5 Billion Acquisition of Capri Holdings
Tapestry Secures Approvals in EU, Japan for Planned $8.5 Billion Acquisition of Capri Holdings
Apr 15, 2024
11:55 AM EDT, 04/15/2024 (MT Newswires) -- Tapestry (TPR) said in a Monday filing that the European Commission and the Fair Trade Commission of Japan have approved the company's planned $8.5 billion acquisition of Capri Holdings ( CPRI ) . The company said the only pending antitrust regulatory approval for the transaction is in the US but the acquisition's completion...
Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?
Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?
Apr 15, 2024
Monday, Viracta Therapeutics Inc ( VIRX ) reported topline results from Stage 1 of the pivotal Phase 2 NAVAL-1 trial from both arms of the relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) peripheral T-cell lymphoma (PTCL) cohort.  Patients were randomized to either nanatinostat monotherapy (n=10) or nanatinostat in combination with valganciclovir (Nana-val, n=10).  Nana-val (nanatinostat in combination with valganciclovir) demonstrated greater efficacy...
What's Going On With Longeveron Stock?
What's Going On With Longeveron Stock?
Apr 15, 2024
Longeveron Inc ( LGVN ). shares are trading higher Monday following insider buys from multiple company executives. Here's a look at what's going on. What To Know: Multiple company executives disclosed large stock purchases after the close on Friday. Joshua Hare, Chief Scientific Officer, purchased 297,872 shares. Rock Soffer, director, purchased 276,596 shares and CEO Mohamed Wa’el Ahmed Hashad purchased...
Copyright 2023-2026 - www.financetom.com All Rights Reserved